Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies.

Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies.

Zobrazit další vydání (1)

PURPOSE: We measured concentrations of human glandular kallikrein 2 (hK2), total prostate specific antigen (tPSA), free PSA (fPSA) and percent fPSA to evaluate their relationship to total prostate gland volume, benign prostatic hyperplasia (BPH) volume, total prostate cancer (PCa) volume (CaVol) an...

Podrobná bibliografie
Hlavní autoři:	Haese, A, Graefen, M, Steuber, T, Becker, C, Noldus, J, Erbersdobler, A, Huland, E, Huland, H, Lilja, H
Médium:	Journal article
Jazyk:	English
Vydáno:	2003

Podobné jednotky

Total and gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies
Autor: Haese, A, a další
Vydáno: (2003)

Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue.
Autor: Steuber, T, a další
Vydáno: (2005)

Human glandular kallikrein 2: a potential serum marker for predicting the organ confined versus non-organ confined growth of prostate cancer.
Autor: Haese, A, a další
Vydáno: (2000)

The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer.
Autor: Haese, A, a další
Vydáno: (2003)

Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigen.
Autor: Steuber, T, a další
Vydáno: (2002)

Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml.
Autor: Haese, A, a další
Vydáno: (2001)

[Isoforms of free prostate-specific antigen]
Autor: Haese, A, a další
Vydáno: (2004)

Isoforms of free prostate-specific antigen
Autor: Haese, A, a další
Vydáno: (2004)

Prostate-specific antigen and related isoforms in the diagnosis and management of prostate cancer.
Autor: Haese, A, a další
Vydáno: (2004)

Prediction of tumor heterogeneity in localized prostate cancer.
Autor: Huland, H, a další
Vydáno: (2002)

Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer.
Autor: Steuber, T, a další
Vydáno: (2007)

Discrimination of prostate cancer from benign disease by selective measurements of serum subfractions of free PSA that are not internally cleaved at Lys145-Lys146
Autor: Nurmikko, P, a další
Vydáno: (2002)

Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and Gleason grade.
Autor: Haese, A, a další
Vydáno: (2005)

Enhanced discrimination of benign from malignant prostatic disease by selective measurements of cleaved forms of urokinase receptor in serum.
Autor: Piironen, T, a další
Vydáno: (2006)

Anti-thrombin is expressed in the benign prostatic epithelium and in prostate cancer and is capable of forming complexes with prostate-specific antigen and human glandular kallikrein 2.
Autor: Cao, Y, a další
Vydáno: (2002)

Age and Prostatic Volume: The Prognosis for Benign Prostatic Hyperplasia
Autor: Dr. Afsheen Khan, a další
Vydáno: (2024-05-01)

Genetic Determinants of Metabolism and Benign Prostate Enlargement: Associations with Prostate Volume.
Autor: Ayush Giri, a další
Vydáno: (2015-01-01)

Association of receptor expression with prostate volume in benign prostatic hyperplasia
Autor: Karli Sreenivasulu, a další
Vydáno: (2019-01-01)

Simultaneous quantification of prostate-specific antigen and human glandular kallikrein 2 mRNA in blood samples from patients with prostate cancer and benign disease.
Autor: Ylikoski, A, a další
Vydáno: (2002)

The role of molecular forms of prostate-specific antigen (PSA or hK3) and of human glandular kallikrein 2 (hK2) in the diagnosis and monitoring of prostate cancer and in extra-prostatic disease.
Autor: Becker, C, a další
Vydáno: (2001)

Relationship of age, prostate-specific antigen, and prostate volume in Indonesian men with benign prostatic hyperplasia
Autor: Ida Bagus O.W. Putra, a další
Vydáno: (2016-06-01)

Association of very low PSA with increased metastases and death in patients with biopsy Gleason score 8-10 prostate cancer
Autor: R.S. Pompe, a další
Vydáno: (2020-07-01)

Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy.
Autor: Steuber, T, a další
Vydáno: (2007)

A study on survivin expression in prostate cancer and benign prostatic hyperplasia; and its association with pre-operative serum prostate specific antigen and gleason score in prostate cancer
Autor: Hadi, Normila Abdul
Vydáno: (2016)

Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum.
Autor: Becker, C, a další
Vydáno: (2000)

Correlation between prostate volume and prostate-specific antigen in patients diagnosed with benign prostatic hyperplasia
Autor: Udoh EA, a další
Vydáno: (2020-12-01)

RELATION OF TOTAL CHOLESTEROL TO PROSTATE VOLUME AND INTRAVESICAL PROSTATIC PROTRUSION IN BENIGN PROSTATIC HYPERPLASIA PATIENTS
Autor: Made Devi Desyana Arisandi, a další
Vydáno: (2021-07-01)

Clinical value of prostate segmentation and volume determination on MRI in benign prostatic hyperplasia
Autor: Brian Garvey, a další
Vydáno: (2014-05-01)

The role of photovaporization of the prostate in small volume benign prostatic hyperplasia and review of the literature
Autor: Dominique Thomas, a další
Vydáno: (2019-10-01)

Study of CD117 Expression and Its Relationship with Benign Prostatic Hyperplasia and Gleason Score in Prostatic Adenocarcinoma
Autor: Mehdi Rahmanpour, a další
Vydáno: (2023-11-01)

Serum prostate specific antigen is a good indicator of prostatic volume in men with benign prostatic hyperplasia
Autor: Ebenezer Abotsi, a další
Vydáno: (2022-12-01)

Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum.
Autor: Steuber, T, a další
Vydáno: (2006)

Association Between Prostate Zonal Volume and Erectile Dysfunction in Patients With Benign Prostatic Hyperplasia
Autor: Muhammed M. Qalawena, MD, a další
Vydáno: (2020-06-01)

EMBOLIZATION AND CHEMOEMBOLIZATION PROSTATIC ARTERIES OF BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER
Autor: N. B. Tabynbaev, a další
Vydáno: (2017-05-01)

Relationship of Prostate-Specific Antigen (PSA) and Prostate Volume in Patients with Biopsy Proven Benign Prostatic Hyperplasia (BPH)
Autor: Aulia Nur Fadila, a další
Vydáno: (2020-07-01)

Renin-angiotensin and kallikrein-kinin systems: a significance in the benign prostatic hyperplasia pathogenesis
Autor: M. B. Chibichyan, a další
Vydáno: (2019-07-01)

Benign Prostate Hyperplasia: Average Volume in Southwestern Nigerians and Correlation with Anthropometrics
Autor: T A Badmus, a další
Vydáno: (2013-01-01)

Benign prostate hyperplasia: average volume in southwestern Nigerians and correlation with anthropometrics
Autor: T A Badmus, a další
Vydáno: (2012-01-01)

Circulating biomarkers for prostate cancer.
Autor: Steuber, T, a další
Vydáno: (2007)

A MICROBIAL CONTAMINATION OF PROSTATIC TISSUE IN BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER
Autor: Y. L. Naboka, a další
Vydáno: (2013-03-01)